This is the text extract for July Tender Notification; Contact: Notifications, browse documents here.

---

29 July 2011

TENDER RESULTS

The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2010/11 Invitation to Tender, dated 2 November 2010. As discussed in our 2010 tender consultation document, we are notifying tender decisions as they are made in 2011. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp. Where a product does not have a current pharmacode, suppliers are required to ensure a pharmacode has been received from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct pharmacode.

A442114 - qA18036

Page 1 of 10

---

Correction of SSS date for ibuprofen 200 mg

The Sole Supply Status expiry date for Ethics Ibuprofen 200 mg tablets had been incorrectly listed in previous Pharmaceutical Schedule Updates as 2012; the correct expiry date for Ethics Ibuprofen 200 mg tablet was 30 June 2011. We apologise for any confusion resulting from the inclusion of the incorrect Sole Supply expiry date in previous Pharmaceutical Schedule Updates. As notified in the June Tender Notification, Arrow-Ibuprofen will have Sole Supply Status from 1 May 2012 – 30 June 2014.

2010/11 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2014 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows: Chemical name Presentation; Pack size and type Tab 250 mg; 100 tablets, bottle Inj 25 mg per ml, 10 ml; 5 ampoules Inj 250 mg; 10 vials Inj 500 mg; 10 vials Inj 1 g; 10 vials Inj 600 mg; 10 vials Tab eff 1.75 g (1 g elemental); 30 tablets, tube Current subsidy and price $10.40 New subsidy and price $17.03 Sole supply brand (Supplier) Diamox (Aspen) DBL Aminophylline (Hospira) Ibiamox (Douglas) Ibiamox (Douglas) Ibiamox (Douglas) Sandoz (Sandoz) Calsource (Novartis) Date of subsidy change Sole Subsidised Supply date

Acetazolamide

1 September 2011

1 December 2011

Aminophylline

$12.84

$53.75

1 September 2011

1 December 2011

Amoxycillin Amoxycillin Amoxycillin Benzylpenicillin sodium (penicillin G) Calcium carbonate

$12.42 $14.24 $21.62 $10.49

$12.96 $15.08 $21.94 $11.50

1 September 2011 1 September 2011 1 September 2011 1 September 2011

1 December 2011 1 December 2011 1 December 2011 1 December 2011

$6.54

$6.21

1 September 2011

1 December 2011

A442114 - qA18036

Page 2 of 10

---

Chemical name

Presentation; Pack size and type Tab 15 mg; 10 tablets, bottle Oral liq 1 mg per ml; 200 ml bottle Crm 1%; 20 g tube, OP Inj 500 mcg per ml, 1 ml; 5 ampoules Inj 250 mg; 10 vials Inj 500 mg; 10 vials Inj 1 g; 10 vials Crm 1%; 500 g jar Powder; 25 g Inj 20 mg, 1 ml; 5 ampoules Cap 250 mg; 100 capules, bottle Tab 100 mg; 24 tablets, blister Crm 2%; 15 g tube, OP

Current subsidy and price $63.89

New subsidy and price $82.45

Sole supply brand (Supplier) DBL Leucovorin Calcium (Hospira) Cetirizine – AFT (AFT) Clomazol (Multichem) DBL Ergometrine (Hospira) Flucloxin (Douglas) Flucloxin (Douglas) Flucloxin (Douglas) Pharmacy Health (API) ABM (ABM) Buscopan (Boehringer Ingelheim) Douglas (Douglas) De-Worm (Multichem) Multichem (Multichem)

Date of subsidy change

Sole Subsidised Supply date

Calcium folinate Cetirizine hydrochloride Clotrimazole Ergometrine maleate Flucloxacillin sodium Flucloxacillin sodium Flucloxacillin sodium Hydrocortisone Hydrocortisone Hyoscine Nbutylbromide Lithium carbonate Mebendazole Miconazole nitrate

1 September 2011

1 December 2011

$3.50 $0.50 $11.60 $9.00 $10.40 $14.00 $12.20 $33.00

$3.52 $0.54 $31.00 $10.86 $11.32 $14.28 $14.00 $44.00

1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

1 December 2011 1 December 2011 1 December 2011 1 December 2011 1 December 2011 1 December 2011 1 December 2011 1 December 2011

$8.04

$9.57

1 September 2011

1 December 2011

$7.73

$9.42 $24.19 $0.46

1 September 2011 1 September 2011 1 September 2011

1 December 2011 1 December 2011 1 December 2011

$17.28

$0.42

A442114 - qA18036

Page 3 of 10

---

Chemical name

Presentation; Pack size and type Inj 5 mg per ml, 1 ml; 5 ampoules Inj 10 mg per ml 1 ml; 5 ampoules Inj 15 mg per ml, 1 ml; 5 ampoules Inj 30 mg per ml, 1 ml; 5 ampoules Tab 5 mg; 100 tablets, blister Inj 50 mg per ml, 1 ml; 5 ampoules Inj 50 mg per ml, 2 ml; 5 ampoules Inj 1.5 mega u; 5 injections Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium; 500 ml bottle Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium; 1,000 ml bottle

Current subsidy and price

$5.17

New subsidy and price $5.51

Sole supply brand (Supplier) DBL Morphine Sulphate (Hospira) DBL Morphine Sulphate (Hospira) DBL Morphine Sulphate (Hospira) DBL Morphine Sulphate (Hospira) Primolut N (Bayer) DBL Pethidine Hydrochloride (Hospira) DBL Pethidine Hydrochloride (Hospira) Cilicaine (Aspen)

Date of subsidy change

Sole Subsidised Supply date

Morphine sulphate

1 September 2011

1 December 2011

Morphine sulphate

$4.50

$4.79

1 September 2011

1 December 2011

Morphine sulphate

$4.70

$5.01

1 September 2011

1 December 2011

Morphine sulphate

$4.98

$5.30

1 September 2011

1 December 2011

Norethisterone Pethidine hydrochloride Pethidine hydrochloride Procaine penicillin Tar with triethanolamine lauryl sulphate and fluorescein Tar with triethanolamine lauryl sulphate and fluorescein

$25.00

$26.50

1 September 2011

1 December 2011

$5.20

$5.51

1 September 2011

1 December 2011

$5.50

$5.83

1 September 2011

1 December 2011

$50.86

$123.50

1 September 2011

1 December 2011

$2.90

$3.05

Pinetarsol (Douglas)

1 September 2011

1 December 2011

$5.54

$5.82

Pinetarsol (Douglas)

1 September 2011

1 December 2011

A442114 - qA18036

Page 4 of 10

---

Chemical name

Presentation; Pack size and type Tab 10 mg; 25 tablets, blister Cap 137.4 mg (50 mg elemental); 100 capsules, bottle

Current subsidy and price

$0.83

New subsidy and price $1.27

Sole supply brand (Supplier) Normison (Aspen) Zincaps (Aspen)

Date of subsidy change

Sole Subsidised Supply date

Temazepam

1 September 2011

1 December 2011

Zinc sulphate

$10.00

$11.00

1 September 2011

1 December 2011

2.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows: Chemical Name Presentation; Pack size and type Current New subsidy subsidy and and price price $9.36 $6.38 (500 mg tabs) (500 mg tabs) $10.18 $7.66 (600 mg tabs) (600 mg tabs) $10.71 $6.96 Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting Calci-Tab 500 (AFT) Calci-Tab 600 (AFT) Zinacef (GSK)

Calcium carbonate

Tab 1.25 g (500 mg elemental); 250 tablets, bottle Inj 750 mg; 5 vials

Arrow-Calcium (Arrow)

1 December 2011

1 February 2012

1 May 2012

Cefuroxime sodium

Multichem (Multichem)

1 January 2012

1 March 2012

1 June 2012

A442114 - qA18036

Page 5 of 10

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

3. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Inj 0.25% with 1:400,000 of adrenaline, 20 ml; 5 vials Tab 1.25 g (500 mg elemental); 250 tablets, bottle Cap 250 mg; 100 capules, bottle Hospital Supply Brand (Supplier) Marcain with Adrenaline (AstraZeneca) Arrow-Calcium (Arrow) Douglas (Douglas) DV Limit 1%

The decisions were as follows:

Chemical Name Bupivacaine hydrochloride with adrenaline Calcium carbonate

Pack price

Listing date

Hospital Supply Status date

$135.00

1 September 2011

1 November 2011

$6.38

1%

1 December 2011

1 February 2012

Lithium carbonate

$9.42

1%

1 September 2011

1 November 2011

4.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Chemical Name Acetazolamide Presentation; Pack size and type Tab 250 mg; 100 tablets, bottle Inj 25 mg per ml, 10 ml; 5 ampoules Inj 250 mg; 10 vials Inj 500 mg; 10 vials Inj 1 g; 10 vials Inj 600 mg; 10 vials Current pack price $10.40 New pack price $17.03 Hospital Supply Brand (Supplier) Diamox (Aspen) DBL Aminophylline (Hospira) Ibiamox (Douglas) Ibiamox (Douglas) Ibiamox (Douglas) Sandoz (Sandoz) DV Limit 1% Date of price change 1 September 2011 Hospital Supply Status date 1 November 2011

The decisions were as follows:

Aminophylline

$12.84

$53.75

1%

1 September 2011

1 November 2011

Amoxycillin Amoxycillin Amoxycillin Benzylpenicillin sodium (penicillin G)

$12.42 $14.24 $21.62 $10.49

$12.96 $15.08 $21.94 $11.50

1% 1% 1% 1%

1 September 2011 1 September 2011 1 September 2011 1 September 2011

1 November 2011 1 November 2011 1 November 2011 1 November 2011

A442114 - qA18036

Page 6 of 10

---

Chemical Name Bupivacaine hydrochloride with adrenaline Bupivacaine Hydrochloride with Fentanyl Bupivacaine Hydrochloride with Fentanyl Bupivacaine Hydrochloride with Fentanyl Bupivacaine Hydrochloride with Fentanyl

Presentation; Pack size and type Inj 0.5% with 1:200,000 of adrenaline, 20 ml; 5 vials Inj 0.125% with 2 mcg fentanyl per ml, 15 ml prefilled syringe; 10 syringes Inj 0.125% with 2 mcg fentanyl per ml, 20 ml prefilled syringe; 10 syringes Inf 0.125% with 2 mcg fentanyl per ml, 100 ml bag; 10 infusions Inf 0.125% with 2 mcg fentanyl per ml, 200 ml bag; 10 infusions Tab eff 1.75 g (1 g elemental); 30 tablets, tube Tab 15 mg; 10 tablets, bottle Oral liq 1 mg per ml; 200 ml bottle Crm 1%; 20 g tube Inj 1 g; 1 vial Inj 2 g; 1 vial

Current pack price $115.40

New pack price $115.00

Hospital Supply Brand (Supplier) Marcain with Adrenaline (AstraZeneca) Biomed (Biomed)

DV Limit 1%

Date of price change

Hospital Supply Status date

1 September 2011

1 November 2011

$61.50

$72.00

1%

1 September 2011

1 November 2011

$78.00

$92.00

Biomed (Biomed)

1%

1 September 2011

1 November 2011

$200.00

$210.00

Bupafen (Biomed)

1%

1 September 2011

1 November 2011

$200.00

$210.00

Bupafen (Biomed)

1%

1 September 2011

1 November 2011

Calcium carbonate

$6.54

$6.21

Calsource (Novartis) DBL Leucovorin Calcium (Hospira) Cetirizine – AFT (AFT) Clomazol (Multichem) Endoxan (Baxter) Endoxan (Baxter)

1%

1 September 2011

1 November 2011

Calcium folinate Cetirizine hydrochloride Clotrimazole Cyclophosphamide* Cyclophosphamide*

$63.89

$82.45

1%

1 September 2011

1 November 2011

$3.50 $0.50 $23.65 $47.30

$3.52 $0.54 $26.70 $56.90

1% 1% 1% 1%

1 September 2011 1 September 2011 1 September 2011 1 September 2011

1 November 2011 1 November 2011 1 November 2011 1 November 2011

A442114 - qA18036

Page 7 of 10

---

Chemical Name Ergometrine maleate Flucloxacillin sodium Flucloxacillin sodium Flucloxacillin sodium Hydrocortisone Hydrocortisone Hyoscine Nbutylbromide Mebendazole Miconazole nitrate

Presentation; Pack size and type Inj 500 mcg per ml, 1 ml; 5 ampoules Inj 250 mg; 10 vials Inj 500 mg; 10 vials Inj 1 g; 10 vials Crm 1%; 500 g jar Powder; 25 g Inj 20 mg, 1 ml; 5 ampoules Tab 100 mg; 24 tablets, blister Crm 2%; 15 g tube Inj 5 mg per ml, 1 ml; 5 ampoules Inj 10 mg per ml 1 ml; 5 ampoules Inj 15 mg per ml, 1 ml; 5 ampoules Inj 30 mg per ml, 1 ml; 5 ampoules

Current pack price $11.60 $9.00 $10.40 $14.00 $12.20 $33.00

New pack price $31.00 $10.86 $11.32 $14.28 $14.00 $44.00

Hospital Supply Brand (Supplier) DBL Ergometrine (Hospira) Flucloxin (Douglas) Flucloxin (Douglas) Flucloxin (Douglas) Pharmacy Health (API) ABM (ABM) Buscopan (Boehringer Ingelheim) De-Worm (Multichem) Multichem (Multichem) DBL Morphine Sulphate (Hospira) DBL Morphine Sulphate (Hospira) DBL Morphine Sulphate (Hospira) DBL Morphine Sulphate (Hospira)

DV Limit 1% 1% 1% 1% 1% 1%

Date of price change 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

Hospital Supply Status date 1 November 2011 1 November 2011 1 November 2011 1 November 2011 1 November 2011 1 November 2011

$8.04

$9.57

1%

1 September 2011

1 November 2011

$17.28 $0.42

$24.19 $0.46

1% 1%

1 September 2011 1 September 2011

1 November 2011 1 November 2011

Morphine sulphate

$5.17

$5.51

1%

1 September 2011

1 November 2011

Morphine sulphate

$4.50

$4.79

1%

1 September 2011

1 November 2011

Morphine sulphate

$4.70

$5.01

1%

1 September 2011

1 November 2011

Morphine sulphate

$4.98

$5.30

1%

1 September 2011

1 November 2011

A442114 - qA18036

Page 8 of 10

---

Chemical Name Norethisterone Pethidine hydrochloride Pethidine hydrochloride Procaine penicillin

Presentation; Pack size and type Tab 5 mg; 100 tablets, blister Inj 50 mg per ml, 1 ml; 5 ampoules Inj 50 mg per ml, 2 ml; 5 ampoules Inj 1.5 mega u; 5 injections Soln 0.9% for irrigation, 30 ml; 30 ampoules Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium; 500 ml bottle Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium; 1,000 ml bottle Tab 10 mg; 25 tablets, blister Cap 137.4 mg (50 mg elemental); 100 capsules, bottle

Current pack price $25.00

New pack price $26.50

Hospital Supply Brand (Supplier) Primolut N (Bayer) DBL Pethidine Hydrochloride (Hospira) DBL Pethidine Hydrochloride (Hospira) Cilicaine (Aspen) Pfizer (Pfizer)

DV Limit 1%

Date of price change 1 September 2011

Hospital Supply Status date 1 November 2011

$5.20

$5.51

1%

1 September 2011

1 November 2011

$5.50

$5.83

1%

1 September 2011

1 November 2011

$50.86

$123.50

1%

1 September 2011

1 November 2011

Sodium chloride

$20.00

$19.50

1%

1 September 2011

1 November 2011

Tar with triethanolamine lauryl sulphate and fluorescein Tar with triethanolamine lauryl sulphate and fluorescein Temazepam

$2.90

$3.05

Pinetarsol (Douglas)

1%

1 September 2011

1 November 2011

$5.54

$5.82

Pinetarsol (Douglas)

1%

1 September 2011

1 November 2011

$0.83

$1.27

Normison (Aspen) Zincaps (Aspen)

1%

1 September 2011

1 November 2011

Zinc sulphate

$10.00

$11.00

1%

1 September 2011

1 November 2011

* The price and subsidy of cyclophosphamide inj 1 g (PCT) and 2 g (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 September 2011. The subsidy for cyclophosphamide 1 mg for ECP remains unchanged.

A442114 - qA18036

Page 9 of 10

---

5.

Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

Presentation; Pack size and type Inj 750 mg; 5 vials Inj 1.5 g; 1 vial Inj 1 mg; 5 vials Inj 2 mg; 5 vials Current pack price $10.71 $4.04 $50.75 $101.50 New pack price $6.96 $2.65 $27.95 $41.80 Hospital Supply Brand (Supplier) Multichem (Multichem) Mylan (Mylan) Remifentanil-AFT (AFT) Remifentanil-AFT (AFT) DV Limit 1% 1% 1% 1% Date of listing/price change for tender winning brand 1 January 2012 1 January 2012 1 November 2011 1 November 2011 Hospital Supply Status date (and delisting of other listed brands) 1 March 2012 1 March 2012 1 January 2012 1 January 2012 Brand (Supplier) to be delisted Zinacef (GSK) Zinacef (GSK) Ultiva (GSK) Ultiva (GSK)

The decisions were as follows:

Chemical Name

Cefuroxime sodium Cefuroxime sodium Remifentanil hydrochloride Remifentanil hydrochloride

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2010/11 Invitation to Tender, dated 2 November 2010:

Chemical Name Cyclophosphamide* Hydrocortisone Line Item Inj 1 g Crm 1% (pack size greater than 15 g and less than 100 g) Chemical Name Mefenamic acid Line Item Cap 250 mg

* Only the community tender for cyclophosphamide inj 1 g has been declined.

For products included in the 2009/10 Invitation to Tender and 2010/11 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A442114 - qA18036

Page 10 of 10